SYNTARA LIMITED — Director's Dealing 2021

Jun 28, 2021

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity PHARMAXIS LTD ABN 75 082 811 630

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

We (the entity) give ASX the followingthe director for the purposes of section	information under listing rule 3.19A.2 and as agent for205G of the Corporations Act.
Name of Director	Malcolm John McComas
Date of last notice	4 May 2021

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest		Indirect
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to the relevantinterest.		Off-market transfer of a total 217,127 sharesfrom McComas Capital Pty Ltd as trustee fora trust of which Mr McComas is abeneficiary and Speech Dynamics Pty Ltd ofwhich Mr McComas is the sole shareholder
		to Bunyula Super Pty Ltd of which MrMcComas is a director and has a beneficial
		interest.
Date of change		25 June 2021
No. of securities held prior to change		Ordinary shares held indirectly: 1,166,361
Class		Ordinary shares

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Number acquired		217,127 ordinary shares
Number disposed		Off-market transfer:217,127 ordinary shares
Value/ConsiderationNote: If consideration is non‐cash, provide details and estimatedvaluation		$0.075 per share
No. of securities held after change		Ordinary shares held indirectly: 1,166,361
Nature of changeExample: on‐market trade, off‐market trade, exercise of options,issue of securities under dividend reinvestment plan, participation inbuy‐back		Off-market transfer of securities

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest
Name of registered holder(if issued securities)
Date of change
No. and class of securities to which interestrelated prior to changeNote: Details are only required for a contract inrelation to which the interest has changed
Interest acquired
Interest disposed

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

==> picture [408 x 63] intentionally omitted <==

----- Start of picture text ----- Value/ConsiderationNote: If consideration is non‐cash, provide detailsand an estimated valuationInterest after change----- End of picture text -----

Part 3 –[+] Closed period

Were the interests in the securities or contracts detailed above tradedduring a+closed period where prior written clearance was required?	No
If so, was prior written clearance provided to allow the trade to proceedduring this period?	n/a
If prior written clearance was provided, on what date was this provided?	n/a

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3